Biomimetic Nano‐Immunoactivator via Ionic Metabolic Modulation for Strengthened NIR‐II Photothermal Immunotherapy
Source abstract
Abstract
Abstract Reprogramming the immunologically “cold” environment of solid tumors is currently becoming the mainstream strategy to elicit powerful and systemic anticancer immunity. Here, a facile and biomimetic nano‐immunnoactivator (CuS/Z@M4T1) is detailed by engineering a Zn2+‐bonded zeolitic imidazolate framework‐8 (ZIF‐8) with CuS nanodots (NDs) and cancer cell membrane for amplified near‐infrared‐II (NIR‐II) photothermal immunotherapy via Zn2+ metabolic modulation. Taking advantage of the NIR‐II photothermal effect of CuS NDs and the acidic responsiveness of ZIF‐8, CuS/Z@M4T1 rapidly causes intracellular Zn2+ pool overload and disturbs the metabolic flux of 4T1 cells, which effectively hamper the production of heat shock proteins and relieve the resistance of photothermal therapy (PTT). Thus, amplified immunogenic cell death is evoked and initiates the immune cascade both in vivo and in vitro as demonstrated by dendritic cells maturation and T‐cell infiltration. Further combination with antiprogrammed death 1 (aPD‐1) achieves escalated antitumor efficacy which eliminates the primary, distant tumor and avidly inhibits lung metastasis due to cooperation of enhanced photothermal stimulation and empowerment of cytotoxic T lymphocytes by aPD‐1. Collectively, this work provides the first report of using the intrinsic modulation property of meta‐organometallic ZIF‐8 for enhanced cancer photoimmunotherapy together with aPD‐1, thereby inspiring a novel combined paradigm of ion‐rich nanomaterials for cancer treatment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Cancer, Stress, Anesthesia, and Immune Response
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy Personalized Drug Therapy Key Laboratory of Sichuan Province Sichuan Provincial People's Hospital and School of Life Science and Technology University of Electronic Science and Technology of China Chengdu Sichuan 610054 P. R. China
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province Hospital of Chengdu University of Traditional Chinese Medicine No. 39 Shi‐er‐qiao Road Chengdu Sichuan 610072 P. R. China
Funding
National Natural Science Foundation of China
References (42)
Show source-provided references
1. 10.1038/nature1067310.1038/nature10673 ↗
2. 10.3322/caac.2159610.3322/caac.21596 ↗
3. 10.1126/scitranslmed.aad711810.1126/scitranslmed.aad7118 ↗
4. 10.1097/COC.000000000000023910.1097/COC.0000000000000239 ↗
5. 10.1038/s41577-019-0218-410.1038/s41577-019-0218-4 ↗
6. 10.1016/j.cell.2017.01.01710.1016/j.cell.2017.01.017 ↗
7. 10.1038/nature1398810.1038/nature13988 ↗
8. 10.1016/j.apsb.2021.08.02010.1016/j.apsb.2021.08.020 ↗
9. 10.1038/nri.2016.10710.1038/nri.2016.107 ↗
10. 10.1158/2326-6066.CIR-15-006410.1158/2326-6066.CIR-15-0064 ↗
11. Chen Y. · Adv. Mater. · 2022 · 34
12. 10.1002/advs.20220471810.1002/advs.202204718 ↗
13. 10.1002/anie.20220002510.1002/anie.202200025 ↗
14. 10.1002/adhm.20210252610.1002/adhm.202102526 ↗
15. 10.1016/j.biomaterials.2021.12093510.1016/j.biomaterials.2021.120935 ↗
16. 10.1016/j.biomaterials.2019.11946310.1016/j.biomaterials.2019.119463 ↗
17. 10.1021/acsnano.9b0246610.1021/acsnano.9b02466 ↗
18. 10.1016/j.biomaterials.2022.12136910.1016/j.biomaterials.2022.121369 ↗
19. 10.1002/viw2.1810.1002/viw2.18 ↗
20. 10.1038/s41556-020-0535-710.1038/s41556-020-0535-7 ↗
21. 10.1126/science.aar451010.1126/science.aar4510 ↗
22. 10.1016/j.canlet.2011.01.02710.1016/j.canlet.2011.01.027 ↗
23. 10.1007/s12576-017-0571-710.1007/s12576-017-0571-7 ↗
24. 10.1038/sigtrans.2017.2910.1038/sigtrans.2017.29 ↗
25. 10.1016/j.abb.2007.02.03310.1016/j.abb.2007.02.033 ↗
26. 10.1016/j.placenta.2006.01.00310.1016/j.placenta.2006.01.003 ↗
27. 10.1002/smll.20220492610.1002/smll.202204926 ↗
28. 10.1016/j.cej.2022.13478110.1016/j.cej.2022.134781 ↗
29. 10.1021/acsnano.2c0553210.1021/acsnano.2c05532 ↗
30. 10.1046/j.1471-4159.2003.01678.x10.1046/j.1471-4159.2003.01678.x ↗
31. 10.1002/advs.20210353410.1002/advs.202103534 ↗
32. 10.1016/j.bioactmat.2022.08.02810.1016/j.bioactmat.2022.08.028 ↗
33. 10.1002/anie.20221530710.1002/anie.202215307 ↗
34. Wang Z. · Chem. Commun. · 2016 · 52 · 1221
35. 10.1002/adfm.20210360010.1002/adfm.202103600 ↗
36. 10.1021/acs.chemmater.2c0038110.1021/acs.chemmater.2c00381 ↗
37. 10.1002/advs.20200439110.1002/advs.202004391 ↗
38. 10.1016/j.apsb.2021.05.00510.1016/j.apsb.2021.05.005 ↗
39. 10.1021/jacs.1c0975310.1021/jacs.1c09753 ↗
40. Huang L. · Nat. Commun. · 2019 · 10
41. 10.1002/wnan.183710.1002/wnan.1837 ↗
42. 10.1002/adhm.20220123310.1002/adhm.202201233 ↗